Evidence map›Paper›PMID 33643083›Full record

SynthesisFrontiers in psychiatry2020

Impact of SARS-CoV-2 Infection on Cognitive Function: A Systematic Review.

Yazen Alnefeesi, Ashley Siegel, Leanna M W Lui, Kayla M Teopiz, Roger C M Ho, Yena Lee, Flora Nasri, Hartej Gill, Kangguang Lin, Bing Cao and 2 more

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Frontiers in psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 4 pooled it
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 4 syntheses or guidelines pooled it, 114 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Resting-state functional connectivity and cognitive impairment after COVID-19 infection: Evidence from a large-scale fMRI study.European psychiatry : the journal of the Association of European Psychiatrists · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Observational
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Yazen AlnefeesiMood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.
Ashley SiegelMood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.
Leanna M W LuiMood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.
Kayla M TeopizMood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.
Roger C M HoDepartment of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Yena LeeMood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.
Flora NasriMood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.
Hartej GillMood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.
Kangguang LinDepartment of Affective Disorder, the Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou Medical University, Guangzhou, China.
Bing CaoKey Laboratory of Cognition and Personality, Faculty of Psychology, Ministry of Education, Southwest University, Chongqing, China.
Joshua D RosenblatMood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.
Roger S McIntyreMood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.
University Health Network · CAGuangzhou Medical University · CNNational University of Singapore · SGSouthwest University · CNUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prevalence and etiology of COVID-19's impact on brain health and cognitive function is poorly characterized. With mounting reports of delirium, systemic inflammation, and evidence of neurotropism, a statement on cognitive impairment among COVID-19 cases is needed. A substantial literature has demonstrated that inflammation can severely disrupt brain function, suggesting an immune response, a cytokine storm, as a possible cause of neurocognitive impairments. In this light, the aim of the present study was to summarize the available knowledge of the impact of COVID-19 on cognition (i.e., herein, we broadly define cognition reflecting the reporting on this topic in the literature) during the acute and recovery phases of the disease, in hospitalized patients and outpatients with confirmed COVID-19 status. A systematic review of the literature identified six studies which document the prevalence of cognitive impairment, and one which quantifies deficits after recovery. Pooling the samples of the included studies (total sample

Indexed as

brain healthcognitive functionCOVID-19cytokinesdeliriumdepressionneuroinflammationneurotropism

Identifiers

PMID33643083
PMCPMC7902710
OpenAlexW3127960175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.